Prior to joining IDDO in Feb-2022 for my WHO/TDR fellowship, I worked as a data manager for the Central Africa Network on Tuberculosis, HIV/AIDS and Malaria (CANTAM) and PANDORA Project in Republic of Congo (2011-2022). At that post, I provided data related support on several biomedical and epidemiological projects including data management for an antimalarial clinical trial at Brazzaville.
During the Covid-19 pandemic, I contributed to the establishment of data management system at my home Institution. I provide statistical support to the research projects at Congolese foundation for Medical Research.
At IDDO, I am looking to further my training on biostatistics and enhance my data skills.
Abdalla Munir holds a B.Sc. in clinical laboratory science from King Saud University (2014) and MSc. In Biochemistry and Molecular Biology (2018).
Currently, he works as clinical data manager at the department of clinical pathology and immunology, Institute of Endemic Diseases (IEND), University of Khartoum. His role involves working on raw clinical trial data (entry, analysis and reporting). Abdalla works closely with the field team reviewing the records and validating the data. Additionally, Abdalla works on non-clinical trials data from previous projects.
Abdalla joined IDDO in April 2022 as WHO/TDR fellow to work on Visceral Leishmaniasis data to understand the importance of host and drug parameters in identifying the areas of unmet needs in treatment of VL.
Aboubakar joined IDDO in February 2022 as an EDCTP-Clinical Research and Product Development Fellow from the Centre MURAZ/NIPH in Burkina Faso.
He trained as a pharmacologist and has research interests on epidemiological aspect of malaria and other infectious diseases such as Covid-19. Over the past five years, his research has focused on in vitro and in vivo assessment of antimalarial drugs and in vitro evaluation of anti-SARS-CoV-2 activity.
At IDDO, he is looking forward to learn and develop broader skills on biostatistics, clinical research data management, and design and conduct of systematic reviews.
Daniel Yilma is academician and a practicing Internal Medicine physician in Jimma University Medical Center (JUMC). He obtained his PhD in University of Copenhagen. He established clinical trial unit at JUMC and conducts infectious disease research mainly on HIV, Tuberculosis, COVID-19 and malaria . Daniel joined IDDO/WWARN as a WHO/TDR fellow and continued his research as a University of Cape Town (UCT) post-doctoral fellow within the Southern African Centre of IDDO based at the UCT Collaborating Centre for Optimising Antimalarial Therapy. He serves as member of malaria case management team at national level. He works with WWARN and other collaborators to find safe, effective and simplified malaria treatment and diagnostic tools.
Trokon joined the IDDO team in November 2018 as a curator. He has been extensively involved with public health data analysis through his management of the fatalities data during the Ebola crisis in Liberia, and now in his current role as Data Manager for the Infectious Disease and Epidemiology Division of the National Public Health Institute of Liberia (NPHIL).
As Data Manager, he is the contact point for harmonising data across multiple sources and introducing electronic collection mechanisms for field data and is increasingly involved in efforts at interoperability and large-scale data curation. This led to answering critical clinical and public health interventions.
Additionally, to his role at NPHIL, he served as the Deputy Pillar Lead on the Epi-surveillance Pillar for the COVID-19 Emergency Response, where he contributed to the development, digitalization, and deployment of data collection tools, thereby yielding informative reports for decision-makers. His contribution reinforces the need to acquire a TDR Fellowship opportunity. Currently, he is a fellow at IDDO, focusing on COVID-19 and Ebola Virus Disease.
Paul joined IDDO in January 2018 as an EDCTP/TDR fellow from the Clinical Research Unit of Nanora in Burkina Faso. He trained as a molecular parasitologist and is interested in Malaria and other parasitic infectious diseases. Over the past five years, his research focusses on assessing the efficacy of antimalarial drugs, studying the genetic diversity of Plasmodium falciparum and exploring the molecular markers associated with antimalarial drug resistance.